Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study.

Trillsch F, Mahner S, Woelber L, Vettorazzi E, Reuss A, Ewald-Riegler N, de Gregorio N, Fotopoulou C, Schmalfeldt B, Burges A, Hilpert F, Fehm T, Meier W, Hillemanns P, Hanker L, Hasenburg A, Strauss HG, Hellriegel M, Wimberger P, Baumann K, Keyver-Paik MD, Canzler U, Wollschlaeger K, Forner D, Pfisterer J, Schroeder W, Muenstedt K, Richter B, Kommoss F, Hauptmann S, du Bois A.

Ann Oncol. 2014 Jul;25(7):1320-7. doi: 10.1093/annonc/mdu119.

PMID:
24618151
2.

Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.

du Bois A, Ewald-Riegler N, de Gregorio N, Reuss A, Mahner S, Fotopoulou C, Kommoss F, Schmalfeldt B, Hilpert F, Fehm T, Burges A, Meier W, Hillemanns P, Hanker L, Hasenburg A, Strauss HG, Hellriegel M, Wimberger P, Keyver-Paik MD, Baumann K, Canzler U, Wollschlaeger K, Forner D, Pfisterer J, Schröder W, Münstedt K, Richter B, Kommoss S, Hauptmann S; Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group..

Eur J Cancer. 2013 May;49(8):1905-14. doi: 10.1016/j.ejca.2013.01.035.

PMID:
23490647
3.

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.

Trillsch F, Mahner S, Vettorazzi E, Woelber L, Reuss A, Baumann K, Keyver-Paik MD, Canzler U, Wollschlaeger K, Forner D, Pfisterer J, Schroeder W, Muenstedt K, Richter B, Fotopoulou C, Schmalfeldt B, Burges A, Ewald-Riegler N, de Gregorio N, Hilpert F, Fehm T, Meier W, Hillemanns P, Hanker L, Hasenburg A, Strauss HG, Hellriegel M, Wimberger P, Kommoss S, Kommoss F, Hauptmann S, du Bois A.

Br J Cancer. 2015 Feb 17;112(4):660-6. doi: 10.1038/bjc.2014.648.

4.

Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.

Vasconcelos I, de Sousa Mendes M.

Eur J Cancer. 2015 Mar;51(5):620-31. doi: 10.1016/j.ejca.2015.01.004. Review.

PMID:
25661104
5.

Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study.

Farthmann J, Hasenburg A, Weil M, Fotopoulou C, Ewald-Riegler N, du Bois O, Trillsch F, Mahner S, Strauss HG, Wimberger P, Reuss A, du Bois A.

Support Care Cancer. 2015 Jan;23(1):117-23. doi: 10.1007/s00520-014-2330-0.

PMID:
24996831
6.

A retrospective study of 27 ovarian tumors of low malignant potential.

Demeter A, Csapó Z, Szánthó A, Bálega J, Sipos N, Papp Z.

Eur J Gynaecol Oncol. 2002;23(5):415-8.

PMID:
12440814
7.

[Retrospective analysis of the clinical outcomes in 12 recurrent borderline ovarian tumor patients with second fertility-sparing surgery].

Chen R, Zhu T, Yu H, Zhu J, Lu X.

Zhonghua Fu Chan Ke Za Zhi. 2014 Apr;49(4):254-9. Chinese.

PMID:
24969331
8.

Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.

Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH.

Gynecol Oncol. 2009 Apr;113(1):75-82. doi: 10.1016/j.ygyno.2008.12.034.

PMID:
19171373
9.

Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor.

Romeo M, Pons F, Barretina P, Radua J.

World J Surg Oncol. 2013 Jan 23;11:13. doi: 10.1186/1477-7819-11-13. Erratum in: World J Surg Oncol. 2016;14(1):226.

10.

Recurrence and prognostic factors in borderline ovarian tumors.

Ayhan A, Guvendag Guven ES, Guven S, Kucukali T.

Gynecol Oncol. 2005 Sep;98(3):439-45.

PMID:
16009407
11.

Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.

Vancraeynest E, Moerman P, Leunen K, Amant F, Neven P, Vergote I.

Int J Gynecol Cancer. 2016 Oct;26(8):1399-406. doi: 10.1097/IGC.0000000000000782.

PMID:
27465897
12.

Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT).

Karlsen NM, Karlsen MA, Høgdall E, Nedergaard L, Christensen IJ, Høgdall C.

Gynecol Oncol. 2016 Jul;142(1):50-3. doi: 10.1016/j.ygyno.2016.05.005.

PMID:
27168006
13.

Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.

Uzan C, Nikpayam M, Ribassin-Majed L, Gouy S, Bendifallah S, Cortez A, Rey A, Duvillard P, Darai E, Morice P.

Ann Oncol. 2014 Jul;25(7):1312-9. doi: 10.1093/annonc/mdu139.

PMID:
24713312
14.

Prognostic factors predicting recurrence in borderline ovarian tumors.

Wu TI, Lee CL, Wu MY, Hsueh S, Huang KG, Yeh CJ, Lai CH.

Gynecol Oncol. 2009 Aug;114(2):237-41. doi: 10.1016/j.ygyno.2009.05.018.

PMID:
19481786
15.

[Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].

Yang ZJ, Wei RJ, Li L.

Zhonghua Fu Chan Ke Za Zhi. 2012 Dec;47(12):898-904. Chinese.

PMID:
23324188
16.

Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.

Ayhan A, Celik H, Taskiran C, Bozdag G, Aksu T.

Eur J Gynaecol Oncol. 2003;24(3-4):223-32. Review.

PMID:
12807228
17.

Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.

Marcickiewicz J, Brännström M.

Acta Obstet Gynecol Scand. 2006;85(12):1496-500.

PMID:
17260228
18.

Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.

Anfinan N, Sait K, Ghatage P, Nation J, Chu P.

Arch Gynecol Obstet. 2011 Sep;284(3):731-5. doi: 10.1007/s00404-010-1713-9.

PMID:
20963432
19.

Prognostic factors and survival of borderline ovarian tumors in Rajavithi Hospital between 1979-2006 A.D.

Sornsukolrat S, Tuipae S.

J Med Assoc Thai. 2012 Sep;95(9):1141-8.

PMID:
23140030
20.

[Clinical and pathological features of borderline ovarian tumors].

Li Y, Cui H, Shen DH, Zhao Y, Wei LH, Qian HN.

Zhonghua Fu Chan Ke Za Zhi. 2003 Feb;38(2):81-4. Chinese.

PMID:
12783693
Items per page

Supplemental Content

Support Center